Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07408154
- Status
- Recruiting
Conditions
- Ocular Hypertension (OHT)
- Open-angle Glaucoma (OAG)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Direct Selective laser Trabeculoplasty — DEVICEThe Direct Selective Laser Trabeculoplasty is a non-contact laser designed to manage IOP in patients with glaucoma. The traditional SLT required a gonioscopy lens to be placed over the patient's eyes to direct the laser towards the trabecular meshwork.
Study Details
This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficiency. Participants will be randomly assigned to receive either DSLT or SLT and followed for 12 months to assess eye pressure, safety, and treatment outcomes.
Key Dates
- Start date
- Apr 27, 2026
- Status verified
- May 2026
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 172 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Direct Selective Laser TrabeculoplastyThis arm is going to receive the Direct SLT treatment
- Active Comparator: Traditional Selective Laser TrabeculoplastyThis arm is going to receive the Traditional SLT treatment which will act as a control for the experimental arm. Note that both lasers are Standard of Care (SOC) and FDA approved
Primary Outcome Measure
Change in Intraocular Pressure at 12 months from baseline [ Time Frame: 12 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MUSC | Charleston | South Carolina | 29407 | Jella An, MD, MBA (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Charleston, SC
By research site
Related Studies
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AlonePHASE4 · Recruiting · Glaukos Corporation · Kenosha, Wisconsin
- Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel DilationPHASE2 · Recruiting · Qlaris Bio, Inc. · Palo Alto, California
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST StudyEnrolling By Invitation · Iantrek, Inc. · Newport Beach, California